You are viewing: France Latent TB Testing Market analysis
Part of: Latent TB Testing Market (Global)

The France Latent TB Testing Market was valued at $22.01 Million in 2024 and projected to reach to $28.29 Million by 2029, representing a compound annual growth rate of 5.2%. France's latent TB testing market is positioned for consistent growth through 2029, driven by strengthened public health awareness campaigns and regulatory compliance requirements for occupational health screening.

France Latent TB Testing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

France Latent TB Testing Market Trends and Insights

  • France's healthcare infrastructure and public health initiatives support steady adoption of latent TB diagnostic solutions across clinical and occupational health settings.
  • The market growth in France reflects increasing awareness of tuberculosis prevention and the importance of early detection in high-risk populations. Driving France's market expansion are enhanced screening protocols in healthcare facilities, immigration-related TB testing requirements, and France's commitment to tuberculosis elimination goals.
  • France continues to invest in diagnostic capabilities and workforce training to improve latent TB identification rates.
  • By 2029, France's latent TB testing market is expected to benefit from technological advances in immunoassays and interferon-gamma release assays, positioning the country as a key contributor to TB control in Western Europe..

Key Market Statistics

  • CAGR (2024-2029) 5.2% CAGR
  • Market Size, 2024 ~USD 22.01 Million
  • Forecast, 2029 ~USD 28.29 Million
  • Country France

France Latent TB Testing Market Overview

Market Valuation :

France's latent TB testing market reached $22.01 million in 2024, with projections to expand to $28.29 million by 2029, representing a steady 5.2% CAGR.

Healthcare Infrastructure Support :

France's robust healthcare system and established public health initiatives create favorable conditions for widespread adoption of latent TB diagnostic solutions across clinical and occupational settings.

Occupational Health Focus :

Growing emphasis on workplace health and safety regulations in France drives demand for latent TB testing in occupational health programs, particularly in high-risk industries.

Diagnostic Innovation Adoption :

Increasing awareness among French healthcare providers and employers regarding latent TB screening benefits accelerates the adoption of advanced diagnostic technologies and testing protocols.

France Latent TB Testing Market Dynamics

  • The country's well-established healthcare infrastructure and emphasis on preventive medicine create a stable foundation for market expansion.
  • Healthcare providers and occupational health services increasingly recognize the importance of early latent TB detection to prevent active disease progression. The French market will benefit from ongoing investments in diagnostic capabilities and integration of latent TB testing into routine occupational health protocols.
  • Collaboration between public health authorities and private healthcare providers is expected to enhance testing accessibility across urban and regional areas, supporting the projected 5.2% CAGR through 2029..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • France's latent TB testing market reached $22.01 million in 2024 with a projected value of $28.29 million by 2029.
    • France is experiencing a 5.2% CAGR, driven by enhanced public health screening and occupational health requirements.
    • France's healthcare system prioritizes TB prevention through systematic latent TB testing in clinical and occupational settings.
    • Technological advancements in diagnostic assays are expected to accelerate market growth in France through 2029.

    Latent TB Testing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment HOUSEHOLD CONTACTS WITH PULMONARY TB (Application)
    Forecast Period 2024-2029
    Growth Rate CAGR of 5.8% from 2024 to 2029
    Largest Segment IGRA (Test Type)
    Market Size Base Year (Billions) ~USD 0.58 (2024)
    Revenue Forecast (Billions) ~USD 0.77 (2029)
    Segments Covered Test Type, Application, End User

    France Latent TB Testing Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Test Type

    • Igra
    • Tst

    By Application

    • Household Contacts With Pulmonary Tb
    • Other Applications
    • People Living With Hiv

    By End User

    • Academic & Research Institutes
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Other End Users

    FRANCE: LATENT TB TESTING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES1.451.651.661.691.731.791.871.953.3
    DIAGNOSTIC LABORATORIES14.3816.6917.1817.8218.6819.7120.9522.375.4
    HOSPITALS & CLINICS4.324.9355.115.275.485.736.033.8
    OTHER END USERS0.860.970.970.9811.031.071.112.8
    TOTAL2124.2424.8125.626.6928.0229.6231.474.9

    Target Audience

    • In Vitro Diagnostics Manufacturers : IVD companies need France-specific market data to develop localized product strategies, identify distribution partnerships, and assess market entry opportunities in latent TB testing.
    • Healthcare System Administrators : French hospital networks and healthcare administrators require market insights to optimize latent TB screening programs, allocate budgets, and improve occupational health compliance.
    • Occupational Health Service Providers : Occupational medicine clinics and workplace health services need France market data to justify testing program investments and align services with growing demand for latent TB screening.
    • Public Health Policy Makers : French health authorities and policy makers use market research to inform TB prevention strategies, allocate public health resources, and develop evidence-based screening guidelines.
    • Investment and Consulting Firms : Private equity, venture capital, and management consultants require France-specific market forecasts to evaluate investment opportunities and advise healthcare clients on market expansion strategies.

    Reasons to Buy this Report

    • France-Specific Market Sizing : Access precise valuation data for France's latent TB testing market with verified 2024 baseline ($22.01M) and 2029 forecasts ($28.29M), enabling accurate business planning and investment decisions.
    • Occupational Health Opportunity Analysis : Understand France's unique occupational health testing requirements and regulatory landscape to identify high-potential segments within clinical and workplace screening programs.
    • Healthcare System Integration Insights : Gain detailed knowledge of how France's healthcare infrastructure supports latent TB testing adoption, including reimbursement pathways and public health collaboration models.
    • Competitive Positioning Strategy : Develop targeted go-to-market strategies for France by understanding regional growth drivers, healthcare provider preferences, and market dynamics specific to the French healthcare ecosystem.
    • Growth Trajectory Forecasting : Leverage France-specific CAGR data (5.2%) and market projections to forecast revenue potential, allocate resources effectively, and benchmark performance against regional market trends.

    Frequently asked questions

    What is the current size of France's latent TB testing market?

    France's latent TB testing market was valued at $22.01 million in 2024 and is expected to reach $28.29 million by 2029.

    What is the growth rate of France's latent TB testing market?

    France's latent TB testing market is growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2029.

    What factors are driving growth in France's latent TB testing market?

    Growth in France is driven by enhanced screening protocols, immigration-related testing requirements, public health initiatives, and technological advances in diagnostic assays.

    Which diagnostic methods are most commonly used in France for latent TB testing?

    France primarily uses interferon-gamma release assays (IGRAs) and tuberculin skin tests (TSTs) as standard diagnostic methods for latent TB detection.

    How does France's latent TB testing market compare to other European countries?

    France maintains a robust latent TB testing market supported by strong healthcare infrastructure and public health commitment, positioning it as a significant contributor to TB control in Western Europe.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the latent TB testing market. Exhaustive secondary research was done to collect information on the latent TB testing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the latent TB testing market.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    The following is a breakdown of the primary respondents:

    Note 1: Others include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    QIAGEN General Manager
    Revvity Area Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the latent TB testing market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • The revenues generated by leading players operating in the latent TB testing market have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    The research methodology used to estimate the market size includes the following:

    Data Triangulation

    After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Latent tuberculosis testing refers to diagnosing the infection by detecting an immune response to Mycobacterium tuberculosis antigens using either the tuberculin skin test (TST) or interferon-gamma release assays (IGRAs). These tests help identify dormant tuberculosis infections in individuals without active symptoms.

    Stakeholders

    • Senior Management
    • End User
    • Finance/Procurement Department  
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global latent TB testing market, by test type, application, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall latent TB testing market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Middle East & Africa, and Latin America
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
    • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

     

    Get the Full Latent TB Testing Market Report

    Full forecast, segment splits, and company analysis for all Latent TB Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status